Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Biodel's Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
Date:5/2/2012
DANBURY, Conn., May 2, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that it has received a notice of allowance from the European Patent Office for patent claims covering Biodel's ultra-rapid-acting insulin formulations intended for the treatment of patients with diabetes. The allowed claims cover formulations containing insulin or an insulin analog as an active agent, in which hexameric insulin dissociates to monomeric or dimeric forms. The formulations are in different forms for subcutaneous or sublingual delivery. Method claims cover use of these formulations to treat patients with Type 1 or Type 2 diabetes by subcutaneous or sublingual delivery. Once issued, the claims will have a term that expires in 2025—twenty years from the filing date of the previously issued parent patent.
Biodel's proprietary formulations allow insulin and insulin analogs to disassociate from the six molecule (hexameric) form to low molecular weight forms (dimeric or monomeric forms) and stabilize the low molecular weight forms, minimizing re-association to the hexameric form. It is believed that this promotes more rapid delivery of insulin into the blood when compared to currently marketed rapid-acting insulin analogs and produces desired biological effects.
Dr. Errol De Souza, Biodel's chief executive officer, stated: "We are gratified by this additional patent coverage, which fortifies the breadth and depth of our multi-pronged ultra-rapid-acting prandial insulin programs. These additional patents are vital to our collaboration and commercialization strategy as we progress our enhanced insulin product candidates through clinical development."
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be saf
'/>"/>
| SOURCE Biodel Inc. Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
2. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
3. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
4. NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds
5. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
6. First iPierian Patent for Induced Pluripotent Stem Cell Technology Granted by United Kingdom Intellectual Property Office
7. Limited Healthcare Infrastructure and Weak Intellectual Property Protection are Among the Challenges Pharma Faces with Emerging Market Expansion
8. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
9. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
10. Small, Smart, Stealth Nanoparticles Seek-and-Destroy Metastatic Cancers, as Epeius Biotechnologies Advances its Intellectual Property Estate With Additional U.S. Patents
11. Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent
Post Your Comments:
(Date:5/20/2013)... YORK , May 20, 2013 Echo Pharma ... 2.5 of the Irish Takeover Rules (the "Announcement"), a ... plc (NYSE: ELN ) to $12.50 per ... cash confirmed and not conditional on due diligence. The ... Royalty Pharma has reserved the right to waive down ...
(Date:5/20/2013)... , May 20, 2013 Atlantic Pharmaceuticals, Inc., ... is commercializing a unique technology to deter prescription ... President, Anthony Soscia , has ... Atlanta Business Chronicle ,s Health-Care Heroes Awards. The ... Business Chronicle to honor individuals and organizations demonstrating ...
(Date:5/20/2013)... May 20, 2013 Rhythm announced today the presentation ... higher prevalence of gastroparesis symptoms among diabetic patients in ... is high among patients with both type 1 and ... among those with the more common type 2 disease. ... MD, PhD, Associate Professor of Medicine at Harvard Medical ...
Breaking Medicine Technology:Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4[0] Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash[0] Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology[0] Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
... Holdings, Inc. (OTC Bulletin Board: CHBP), an integrated bio-pharmaceutical ... today that its shareholders have approved the acquisition of ... by an overwhelming vote in favor of approximately 80% ... was obtained at a Special Meeting of Stockholders held ...
... Mass., Oct. 29 /PRNewswire-FirstCall/ -- Echo ... management company developing the needle-free Symphony(TM) tCGM System ... (tCGM) system and the Prelude(TM) SkinPrep System for ... made significant advances to the development of its ...
Cached Medicine Technology:China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol 'NBS' 2China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol 'NBS' 3Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor 2Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor 3(Date:5/20/2013)... NL, 20 May 2013 While Huntington,s disease ... anticipates that new disease-modifying therapies in development may ... of HD research depends upon the identification of ... evaluate therapies, and these biomarkers may eventually be ... could be especially helpful to monitor changes during ...
(Date:5/20/2013)... Horizon NJ Health, New Jersey’s largest ... it has earned a Commendable Accreditation status from ... Health is a wholly owned subsidiary of Horizon Blue ... Health Plan Accreditation is a nationally recognized program that ... plans provide to their members. Health Plan Accreditation performance ...
(Date:5/20/2013)... May 20, 2013 The American Society ... for Bright Pink®, the organization that empowers young women to ... end of 2012. Thanks to its members, ASCP raised more ... is involved in Relay for Life at the local level. ... he decided to donate. “I was made aware of the ...
(Date:5/20/2013)... The nationwide law firm of Bernstein Liebhard LLP ... imaging (MRI) can be used to predict metal-on-metal hip ... experiencing symptoms. According to an article published on May ... MRI detected synovitis (tissue damage) in 68% of asymptomatic patients ... causes, the detection rate was 75%, while MRIs were able ...
(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- Boys who are ... likely to become obese adults as those who didn,t ... 30-year study shows. Researchers found that men with ... (BMI) and obesity, even if they no longer had ... well-off or poor, they tended toward obesity. "The ...
Breaking Medicine News(10 mins):Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 2Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 3Health News:ASCP Members Rally Around Breast and Ovarian Cancer Awareness 2Health News:ASCP Members Rally Around Breast and Ovarian Cancer Awareness 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3[0] Leading researchers report on the elusive search for biomarkers in Huntington's disease[0] Horizon NJ Health Awarded Commendable Accreditation by NCQA[0] ASCP Members Rally Around Breast and Ovarian Cancer Awareness[0] Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure[0] ADHD in Childhood May Raise Risk for Obesity in Adulthood
... Researchers may have found a more potent risk factor for melanoma ... disease. In a new study, scientists at NYU Langone Medical Center ... of melanoma in women under the age of 50. The ... Clinical Cancer Research and will be published in the ...
... N.C. Numerous studies have shown a relationship between ... with breast cancer. In a study published today in ... , an investigation of coping strategies and quality of ... QOL determines the use of coping strategies. , "It ...
... March 24 The American Cancer Society Cancer Action ... and the Campaign for Tobacco-Free Kids applaud Senator Frank ... Drug Administration to exert its authority and immediately remove ... quoted numerous times in many publications during the past ...
... emphasizes values-based curriculum PHOENIX, March 24 In answer ... the need for more values-driven leaders, Grand Canyon ... it rewards to high academic achievers as well as ... is our own higher education stimulus package," said GCU ...
... educate Americans about their risk of type 2 diabetesPORT ST. ... Day. The American Diabetes Association urges all Americans to ... it. To help educate the public, the American Diabetes ... Supply, Inc., have teamed up to provide an online video ...
... behavioral traits, susceptibility to certain diseases , , TUESDAY, ... 1,362 copy number variations (CNVs) in the human genome ... -- differences in gene copy numbers caused by deletions, ... a large amount of human diversity and can also ...
Cached Medicine News:Health News:NYU study finds new risk factor for melanoma in younger women 2Health News:NYU study finds new risk factor for melanoma in younger women 3Health News:Quality of life may impact coping strategies of young women with breast cancer 2Health News:Quality of life may impact coping strategies of young women with breast cancer 3Health News:Statement of the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and the Campaign for Tobacco-Free Kids 2Health News:Grand Canyon University Increases Academic Scholarships 2Health News:Grand Canyon University Increases Academic Scholarships 3Health News:American Diabetes Association Alert(R) Day Video - Do You Have Diabetes? 2Health News:American Diabetes Association Alert(R) Day Video - Do You Have Diabetes? 3Health News:American Diabetes Association Alert(R) Day Video - Do You Have Diabetes? 4Health News:Study IDs Variations in Black, White Genomes 2NYU study finds new risk factor for melanoma in younger womenQuality of life may impact coping strategies of young women with breast cancerStatement of the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and the Campaign for Tobacco-Free KidsGrand Canyon University Increases Academic ScholarshipsAmerican Diabetes Association Alert(R) Day Video - Do You Have Diabetes?Study IDs Variations in Black, White Genomes
Reciprocating shaker specifically for platelet bags....
... by the adrenal cortex, the corpus luteum, ... other steroids, progesterone is synthesized from cholesterol ... Progesterone produced by the adrenal cortex and ... steroidogenic pathways, with only a small amount ...
No cross-reaction with human pro-insulin and C-peptide....
ELISA for the detection of Insulin....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |